B69.81
Myositis in cysticercosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Myositis in cysticercosis is a condition characterized by muscle inflammation caused by a parasitic infection known as cysticercosis. Cysticercosis occurs when the larvae of the tapeworm *Taenia solium* invade various tissues, including muscles, leading to inflammation and associated symptoms. The condition is prevalent in areas with poor sanitation where the lifecycle of the tapeworm is more easily maintained.
Causes & Symptoms
Clinical Causes: Ingestion of food or water contaminated with tapeworm eggs Poor hygiene and sanitation practices Contaminated pork products carrying cysticerci Fecal-oral transmission from person to person
Key Symptoms: Muscle pain and tenderness Swelling or lumps in affected muscles Muscle weakness or fatigue Localized muscle stiffness In some cases, visible cysts under the skin
Diagnostic & Treatment
Diagnosis Path: Imaging studies such as MRI or CT scans to identify cysts or inflammation in muscles Serological tests to detect antibodies against *Taenia solium* Muscle biopsy to confirm the presence of cysticerci Blood tests to assess overall health and inflammation levels
Treatment Protocols: Antiparasitic medications such as albendazole or praziquantel to kill cysticerci Use of corticosteroids to decrease inflammation and manage symptoms Supportive therapies like pain relievers and rest Monitoring and follow-up imaging to evaluate treatment effectiveness
Clinical Advice & FAQs
Billing Guidance
Is B69.81 a billable ICD-10 code?
Yes, B69.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B69.81?
Clinical documentation must specify the nature of Myositis in cysticercosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference